| The Calmer Co International Limited (CCO) ORDINARY FULLY PAID |
Consumer Staple |
$9 |
Appendix 4G
|
30 Aug 2024 1:30PM |
$0.009 |
$0.003 |
fallen by
64.71%
|
|
| FMR Resources Limited (FMR) ORDINARY FULLY PAID |
Communication Services |
$14 |
Appendix 4G & Corporate Governance Statement
|
30 Aug 2024 1:30PM |
$0.170 |
$0.365 |
risen by
114.71%
|
|
| FMR Resources Limited (FMR) ORDINARY FULLY PAID |
Communication Services |
$14 |
Appendix 4E & Annual Report
|
30 Aug 2024 1:29PM |
$0.170 |
$0.365 |
risen by
114.71%
|
|
FMR - Price-sensitive ASX Announcement
Full Release
Key Points
- FMR Resources Limited completed several significant transactions, including the acquisition of Canada Future Metals Pty Ltd and disposal of the Applyflow business.
- The company shifted its principal activities from HR technology products to minerals exploration in Canada.
- FMR Resources Limited underwent a re-compliance listing on ASX and consolidated its securities.
- Financial performance for FY24 showed a substantial reduction in loss after tax, from $3,208,029 in 2023 to $538,263 in 2024.
- No dividends were paid, recommended, or declared during the current or previous financial year.
- The company's cash and cash equivalents increased from $3,335,306 in 2023 to $4,285,215 in 2024.
- Net tangible assets per share rose significantly from 1.25 cents to 20.67 cents.
- The company was reinstated to the ASX Official List on 3 July 2024 following re-compliance with listing rules.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| The Calmer Co International Limited (CCO) ORDINARY FULLY PAID |
Consumer Staple |
$9 |
Preliminary Final Report
|
30 Aug 2024 1:29PM |
$0.009 |
$0.003 |
fallen by
64.71%
|
|
CCO - Price-sensitive ASX Announcement
Full Release
Key Points
- Report for the period ended 30 June 2024 with a previous corresponding period of 30 June 2023.
- Revenues from ordinary activities increased by 139% to $4,262,840.
- Loss from ordinary activities after tax attributable to members decreased by 30% to $3,726,655.
- No dividends were declared for both interim and final periods.
- Net tangible liabilities/assets backing per share improved from (0.21c) to (0.06c).
- No control was gained or lost over any entities during the period.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Income Asset Management Group Limited (IAM) ORDINARY FULLY PAID |
Financials |
$42 |
IAM FY24 Results Commentary
|
30 Aug 2024 1:28PM |
$0.065 |
$0.045 |
fallen by
30.77%
|
|
IAM - Price-sensitive ASX Announcement
Full Release
Key Points
- IAM is conducting due diligence on outsourcing its platform solution to save around $4m per annum in FY25.
- IAM wrote down the Cashwerkz technology platform and its investment in Alpha Vista Financial Services, totaling $7m in non-cash write downs.
- IAM's revenue for FY24 was consistent with FY23, with significant improvement each quarter.
- IAM closed its Funds Management Division due to profitability challenges.
- Increased Assets under Administration (AuA) from $3.1bn to $3.69bn, a 19% YOY increase.
- Increased client numbers from 1304 to 2153, a 65% YOY increase.
- IAM's total staff number declined slightly to 54 people, with a focus on increasing sales FTE ratio.
- IAM CEO Jon Lechte highlighted strong revenue growth and new client acquisitions in Q4 FY24.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Income Asset Management Group Limited (IAM) ORDINARY FULLY PAID |
Financials |
$42 |
Appendix 4G
|
30 Aug 2024 1:26PM |
$0.065 |
$0.045 |
fallen by
30.77%
|
|
| Fluence Corporation Limited (FLC) ORDINARY FULLY PAID |
Utilities |
$73 |
Appendix 4D and Half Year Accounts
|
30 Aug 2024 1:26PM |
$0.097 |
$0.067 |
fallen by
30.93%
|
|
FLC - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenues from ordinary activities from continuing operations decreased by 34% to $20,070,000
- Loss from ordinary activities after tax attributable to the Owners of Fluence Corporation Limited increased by 9% to $9,498,000
- No dividends were paid, recommended, or declared during the current financial period
- Net tangible assets per ordinary security decreased from 0.89 cents to 0.10 cents
- Fluence replaced the Upwell Facility with a new revolving credit facility for up to $15 million
- Municipal Water and Wastewater (MWW) revenue in North America increased by $0.5 million or 37%
- Significant cost savings expected from the elimination of commercial operations in Israel
- H1 2024 SPS plus Recurring Revenue grew by 14% over H1 2023
- Gross margins increased by 8.7% to 30.2% in H1 2024
- Total backlog increased by 83% to $96.6 million as of 30 June 2024
- Cash balance was $7.9 million plus $7.8 million in security deposits as at June 30, 2024
- Fluence forecasts operating cash flow to be positive for the balance of FY2024
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| MA Financial Group Limited (MAF) ORDINARY FULLY PAID |
Financials |
$1,691 |
Appendix 3Y - Julian Biggins
|
30 Aug 2024 1:24PM |
$5.310 |
$9.220 |
risen by
73.63%
|
|
| MA Financial Group Limited (MAF) ORDINARY FULLY PAID |
Financials |
$1,691 |
Appendix 3Y - Christopher Wyke
|
30 Aug 2024 1:24PM |
$5.310 |
$9.220 |
risen by
73.63%
|
|
| Cann Group Limited (CAN) ORDINARY FULLY PAID |
Health Care |
$9 |
Cann releases FY24 results
|
30 Aug 2024 1:23PM |
$0.043 |
$0.014 |
fallen by
67.44%
|
|
CAN - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue from sales increased by 11.6% to $15.73 million.
- EBITDA loss improved by $4.20 million (34%) to $13.2 million.
- Commercial production increased by over 100% to 4.43 tonnes.
- Jenni Pilcher was appointed CEO & Managing Director effective 1 April 2024.
- Sales revenue was impacted by ASX suspension from 1 March 2024 to 4 June 2024.
- Dried flower sales increased by 49% to $8.69 million, with Botanitech brand sales growing 87% to $2.26 million.
- Bulk dried flower sales contributed $1.67 million to sales revenue.
- Oil sales declined by 29%, attributed to a market shift towards dried flower and cheaper imports.
- New contract packing services launched in June 2023 contributed $1.19 million to sales revenue.
- The Company raised $13.16 million from equity, new debt facilities, and asset sales.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| MA Financial Group Limited (MAF) ORDINARY FULLY PAID |
Financials |
$1,691 |
Appendix 3Y & Change in substantial holding - Andrew Pridham
|
30 Aug 2024 1:23PM |
$5.310 |
$9.220 |
risen by
73.63%
|
|
| Australian Dairy Nutritionals Group (AHF) ORDINARY FULLY PAID |
Consumer Staple |
$33 |
Corporate Governance Statement and Appendix 4G
|
30 Aug 2024 1:22PM |
$0.019 |
$0.044 |
risen by
131.58%
|
|
| Income Asset Management Group Limited (IAM) ORDINARY FULLY PAID |
Financials |
$42 |
Corporate Governance Statement
|
30 Aug 2024 1:21PM |
$0.065 |
$0.045 |
fallen by
30.77%
|
|
| Australian Dairy Nutritionals Group (AHF) ORDINARY FULLY PAID |
Consumer Staple |
$33 |
Appendix 4E and Annual Report to Shareholders
|
30 Aug 2024 1:21PM |
$0.019 |
$0.044 |
risen by
131.58%
|
|
AHF - Price-sensitive ASX Announcement
Full Release
Key Points
- Ownership and operation of dairy farms and livestock
- Manufacture of Ocean Road Dairies Organic A2 infant formula
- Distribution through Organic Nutritionals Pty Ltd
- Revenue growth to $6.26 million in FY24
- Net loss of $7.44 million in FY24
- Strategic review and new direction planned for FY25
- Partnership with Vietnam distributor Dunamex
- No dividends declared for the year ended 30 June 2024
- Board and management changes and cost review undertaken
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Income Asset Management Group Limited (IAM) ORDINARY FULLY PAID |
Financials |
$42 |
Annual Report to shareholders
|
30 Aug 2024 1:21PM |
$0.065 |
$0.045 |
fallen by
30.77%
|
|
| Raiden Resources Limited (RDN) ORDINARY FULLY PAID |
Materials |
$14 |
Notice under section 708A(5)(e)
|
30 Aug 2024 1:20PM |
$0.027 |
$0.004 |
fallen by
85.19%
|
|
| Income Asset Management Group Limited (IAM) ORDINARY FULLY PAID |
Financials |
$42 |
Appendix 4E
|
30 Aug 2024 1:20PM |
$0.065 |
$0.045 |
fallen by
30.77%
|
|
IAM - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue from ordinary activities increased by 1% to $14,018,000
- Loss from ordinary activities after tax attributable to members increased by 124% to $14,471,000
- Overall loss for the period attributable to members increased by 177% to $17,859,000
- No dividends were declared or paid during the reporting period
- Net tangible asset backing per ordinary security decreased from 1.3 cents to -1.7 cents
- The Group registered a new 100% owned subsidiary, ETB Pty Ltd, for the Exchange Traded Bonds (ETB) business
- The share of net losses of associate entities for the year ended 30 June 2024 is $116,793
- Refer to Annual Report pages 11-16 for commentary on results
- Annual Report includes additional Appendix 4E disclosure requirements
- Annual Report has been audited with the Independent Auditor’s Report included
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Cann Group Limited (CAN) ORDINARY FULLY PAID |
Health Care |
$9 |
Full Year Statutory Accounts and Appendix 4E
|
30 Aug 2024 1:18PM |
$0.043 |
$0.014 |
fallen by
67.44%
|
|
CAN - Price-sensitive ASX Announcement
Full Release
Key Points
- The company reported a revenue and other income of $19.07 million for the year ended 30 June 2024, a decrease of 12% from the previous year.
- The net loss after tax increased by 52% to $51.24 million compared to the previous year.
- Net tangible assets per ordinary security dropped from $0.15 to $0.03.
- Material uncertainty related to going concern was noted by the auditors.
- Revenue from customer contracts rose by 11.6% to $15.37 million.
- Dried flower sales increased by 49%, with own-brand 'Botanitech' sales growing 87% over the prior year.
- Production output at Mildura for the year was 4.43 tonnes, doubling from the previous year.
- The company raised $4.46 million in a non-renounceable rights issue but failed to meet the intended target of $11.7 million.
- The company secured a $5 million debt facility with a private credit fund, subject to a 15% interest rate per annum.
- Several new funding options are being explored, including a potential sale and leaseback of the Mildura facility and a $3 million convertible note facility.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Lincoln Minerals Limited (LML) ORDINARY FULLY PAID |
Materials |
$19 |
FY24 Full Year Statutory Accounts
|
30 Aug 2024 1:15PM |
$0.005 |
$0.009 |
risen by
80%
|
|
| The Hydration Pharmaceuticals Company Limited (HPC) ORDINARY FULLY PAID |
Consumer Staple |
$5 |
FY24 Half Year Results Announcement
|
30 Aug 2024 1:14PM |
$0.009 |
$0.011 |
risen by
22.22%
|
|
HPC - Price-sensitive ASX Announcement
Full Release
Key Points
- 34% reduction in EBITDA loss to $2.4m
- Gross margin increased by 4ppt to 53%
- Reduction in marketing spend by 11ppt to $1.5m, 31% of net sales
- YoY net sales decreased slightly to $5.0m
- Significant impact from Rite Aid's bankruptcy and inventory issues at Shoppers Drug Mart
- Positive outlook for H2 2024 with recovery expected in sales to Rite Aid and additional sales to Shoppers Drug Mart
- Gross profit increased by 2% to $2.62m
- Strong second quarter gross profit up 8% from previous corresponding period to $1.5m
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Adslot Ltd (ADS) ORDINARY FULLY PAID |
Information Technology |
$6 |
Appendix 4E & Preliminary Financial Statements - 2024
|
30 Aug 2024 1:13PM |
$0.001 |
$0.001 |
fallen by
0%
|
|
ADS - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue from ordinary activities decreased by 5.24% to $8,746,714.
- Net loss attributable to members reduced by 11.38% to $10,703,881.
- EBITDA loss improved by 9% to $7,582,565.
- Impairments of intangible assets and right-of-use assets totaled $5,487,106.
- No dividends were proposed for the reporting period.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| PainChek Ltd (PCK) ORDINARY FULLY PAID |
Health Care |
$84 |
Preliminary Final Report
|
30 Aug 2024 1:13PM |
$0.035 |
$0.041 |
risen by
17.14%
|
|
PCK - Price-sensitive ASX Announcement
Full Release
Key Points
- PainChek technology uses facial recognition software to assess pain in non-verbal individuals.
- Global expansion with 95,000 adult app licenses contracted in ANZ, UK, and Canada.
- Preparation for US market entry with FDA submission targeting late 2024.
- Initial market introduction of PainChek Infant App in Australia.
- Annual Recurring Revenue (ARR) of $4.6M from global adult licenses.
- Significant investments in clinical trials and technology upgrades.
- Total revenue for 2024 was $2.67M, with continued investment in R&D.
- Loss for the year was $8.3M, with major expenses in research, marketing, and corporate administration.
- Plans for broad commercial launch of PainChek Infant during FY2025.
- Strong sales pipeline and client retention rates at 85%.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Hubify Limited (HFY) ORDINARY FULLY PAID |
Communication Services |
$4 |
Appendix 4E and Annual Report
|
30 Aug 2024 1:13PM |
$0.012 |
$0.008 |
fallen by
33.33%
|
|
HFY - Price-sensitive ASX Announcement
Full Release
Key Points
- Hubify Limited (ASX:HFY) is a leading provider of Telco, IT Technology & Managed Services to Australian businesses.
- The company recorded an underlying EBITDA loss of $1.1m for FY24 with an annual statutory net loss after tax of $4.7m.
- Total revenue for the period was $19.7m, a 24% decrease compared to the prior year driven by the divestment of the Optus SMB mobility business.
- Managed Services and Communications make up 85% of total revenue with Managed Services experiencing a 15% year-on-year growth in FY24.
- Recurring revenue constituted 87% of total revenue.
- The company maintained zero debt and a cash balance of $2.8m at the end of the fiscal year.
- The financial statements have been prepared on a going concern basis.
- Key achievements include winning several new clients across various industries such as retail, pubs & clubs, recruitment, FMCG, and NDIS.
- Significant changes during FY24 included the divestment of the Mobility Small Business Reseller Program with Optus and a strategic focus on scalable Managed Service Providers (MSP) business.
- The company's strategy includes both organic growth and acquisitions to scale and become a major player in Managed Services for Australian businesses.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| The Hydration Pharmaceuticals Company Limited (HPC) ORDINARY FULLY PAID |
Consumer Staple |
$5 |
Appendix 4D and FY24 Half Year Financial Report
|
30 Aug 2024 1:10PM |
$0.009 |
$0.011 |
risen by
22.22%
|
|
HPC - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue from ordinary activities decreased by 6% to $5.0m
- Loss from ordinary activities after tax decreased by 12% to $3.1m
- EBITDA loss decreased by 34% to $2.4m
- Gross margin increased by 4 percentage points to 53%
- Canadian eComm revenue grew by 52% to $1.1m
- US traditional retail net revenue declined by 21% to $1.8m due to Rite Aid bankruptcy
- Net cash used in operating activities declined by 29% to $2.1m
- No dividends were paid, recommended, or declared
- The company's focus has been on cash preservation and improved profitability
- Hydralyte secured A$1.7 million in new funding under an Amended PURE Facility
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Integral Diagnostics Limited (IDX) ORDINARY FULLY PAID |
Health Care |
$998 |
Change of Director's Interest Notice - Ian Kadish
|
30 Aug 2024 1:07PM |
$2.595 |
$2.680 |
risen by
3.28%
|
|
Goals & planningInvesting goal hubsSaving to build wealth
Saving for happy retirement 
Call 1300 880 160
Start a chat
Schedule a call
